One article in Pubmed reported that iPSCs-derived from T1D patients had a lower efficiency in functional pancreatic β cells and Pdx1 expression compared with nondiabetic iPSCs (109). This evidence concerns the gene PDX1 and type 1 diabetes mellitus.